SynthesisPharmaceutical biology2021

Efficacy and safety of Chinese patent medicine (Kang-ai injection) as an adjuvant in the treatment of patients with hepatocellular carcinoma: a meta-analysis.

Chuihua Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.